UCLA Health’s Dr. Kymora B. Scotland has been recognized by the Endourological Society’s 2026 Arthur Smith Award, an honor granted to urologists who are within 10 years of completing their residency or fellowship.
The society gives the award annually to a physician “who has already achieved distinction through myriad contributions to the field of Endourology in research and teaching.”
Dr. Scotland is assistant professor and director of endourology research at the UCLA’s David Geffen School of Medicine. Her clinical expertise is in kidney stone treatment, as well as management of benign prostatic hyperplasia and upper tract urothelial carcinoma. Her research investigates kidney stone pathogenesis and stone-associated infection. She recently edited the book The Role of Bacteria in Urology and is the vice-president of the Society for Infection and Inflammation in Urology.
"Dr. Scotland exemplifies all the qualities of an impactful clinician, scientist and mentor. This honor from the Endourological Society is a fitting recognition of her contributions," said Dr. Scott Eggener, professor and chair of UCLA Health’s Department of Urology.
Dr. Scotland has a particular clinical research interest in developing techniques aimed at improving quality of life for nephrolithiasis patients and has focused recent work on patient engagement with stone management regimens.
Dr. Scotland has been multiply-funded by the NIH and the Urology Care Foundation. She has also received awards from the AUA including Young Urologist of the year for her community and mentorship work and the Rising Star Award for her laboratory research. She is the President of the Collaborative for Research in Endourology (CoRE), an international group of endourologists focused on developing innovative solutions to the care of kidney stone patients.
